Avidity Biosciences, Inc.（RNAM）内部人交易：高管与董事近期交易
过去 18 个月，共有 17 位内部人为 Avidity Biosciences, Inc.（RNAM）报告了 19 笔 Form 4 交易（最近一笔 2026-02-27）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-02-27 | BOESS CARSTEN | 董事 | 卖出 | 6,692 | $0 |
| 2026-02-27 | Moriarty John B | Chief Legal Officer | 卖出 | 92,054 | $0 |
| 2026-02-27 | Kaye Edward M. MD | 董事 | 卖出 | 6,692 | $0 |
| 2026-02-27 | Boyce Sarah | President and CEO | 卖出 | 474,861 | $0 |
| 2026-02-27 | Skerjanec Simona | 董事 | 卖出 | 6,692 | $0 |
| 2026-02-27 | Hughes Steven George | Chief Medical Officer | 卖出 | 115,857 | $0 |
| 2026-02-27 | McCarthy Teresa | Chief Human Resources Officer | 卖出 | 165,296 | $0 |
| 2026-02-27 | Gallagher Kathleen P. | Chief Program Officer | 卖出 | 80,303 | $0 |
| 2026-02-27 | Mosbrooker Eric | Chief Commercial Officer | 卖出 | 79,413 | $0 |
| 2026-02-27 | Henig Noreen | 董事 | 卖出 | 6,692 | $0 |
| 2026-02-27 | WILSON TROY EDWARD | 董事 | 卖出 | 65,091 | $0 |
| 2026-02-27 | WILSON TROY EDWARD | 董事 | 卖出 | 13,711 | $0 |
| 2026-02-27 | MacLean Michael F | Chief Financial Officer | 卖出 | 133,977 | $0 |
| 2026-02-27 | Thompson Tamar | 董事 | 卖出 | 6,692 | $0 |
| 2026-02-27 | Calderaro Charles III | Chief Technical Officer | 卖出 | 98,547 | $0 |
| 2026-02-27 | Flanagan W. Michael | Chief Scientific Officer | 卖出 | 150,365 | $0 |
| 2026-02-27 | Kim Jean Jinsun | 董事 | 卖出 | 6,692 | $0 |
| 2026-02-27 | LEVIN ARTHUR A | 董事 | 卖出 | 16,562 | $0 |
| 2026-02-27 | LEVIN ARTHUR A | 董事 | 卖出 | 131,372 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-02-27